Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
4.205
+0.010 (0.24%)
Sep 28, 2026, 10:11 AM EDT - Market open
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $5.65 million as of September 28, 2026. Its market cap has decreased by -85.03% in one year.
Market Cap
5.65M
Enterprise Value
4.07M
1-Year Change
-85.03%
Ranking
Category
Stock Price
$4.21
ChartMarket Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $5.65M, a decrease of -98.37%. That is a compound annual growth rate of -53.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 5.65M | -65.79% |
| Dec 31, 2025 | 16.51M | -79.39% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
| May 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Processa Pharmaceuticals | 6.17M |
| Pulmatrix | 5.88M |
| Kairos Pharma | 5.82M |
| AIM ImmunoTech | 5.79M |
| Cardio Diagnostics Holdings | 5.77M |
| Ernexa Therapeutics | 5.62M |
| Xenetic Biosciences | 5.60M |
| NuCana | 5.52M |